SCHEMBL2522911

SCHEMBL2522911

CCOc1cccc(C)c1OCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.47
▸ PTPN1 P18031 1/20 0.45
▸ KDM4E B2RXH2 4/20 0.43
▸ MAPT P10636 4/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ PABPC1 P11940 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ GRK6 P43250 1/20 0.43
▸ SCN4A P35499 3/20 0.42
▸ LMNA P02545 3/20 0.42
▸ SCN1A P35498 2/20 0.42
▸ SCN5A Q14524 2/20 0.42
▸ SCN9A Q15858 2/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ NFKB1 P19838 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16958650 0.88 CHRM2 (0.43) PTPN1KDM4EMAPTTDP1LMNA
SCHEMBL14612800 0.88 SMN1; SMN2 (0.53) ALDH1A1PTPN1KDM4EMAPTKMT2A
SCHEMBL3077213 0.88 ALDH1A1 (0.44) ALDH1A1PTPN1KDM4EMAPTMEN1
SCHEMBL147753 0.86 SCN4A (0.54) ALDH1A1KDM4EMAPTSCN4ALMNA
SCHEMBL2068454 0.86 ALDH1A1 (0.54) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL16959326 0.83 SCN4A (0.44) PTPN1MAPTMEN1KMT2ATDP1
Potassium Ion SCHEMBL28222970 0.82 ALDH1A1 (0.50) ALDH1A1KDM4EMAPTMEN1KMT2A
Methyl Alcohol SCHEMBL28171303 0.82 ALDH1A1 (0.50) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL16479216 0.81 SCN8A (0.42) ALDH1A1PTPN1SCN4ALMNASCN1A
SCHEMBL16961866 0.81 MEN1 (0.44) ALDH1A1PTPN1MEN1KMT2ASCN4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0926119-A1 Dialkoxybenzene electron donors UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1999-06-30 — — EP claimed
US-4272634-A Process for the production of intermediate oxidation products of toluenes having ether linkages DIRECTOR-GENERAL OF AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 1981-06-09 — — US claimed
EP-3626802-B1 METHOD FOR PRODUCING LIQUID COMPOSITION SUMITOMO CHEMICAL CO (JP) 2024-12-25 — — EP disclosed
US-11852970-B2 Material for lithography, production method therefor, composition for lithography, pattern formation method, compound, resin, and method for purifying the compound or the resin MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2023-12-26 — — US disclosed
CN-115702132-A Composition for enhancing nitrogen stabilizers, method and use thereof 沃戴申生命科学美国有限责任公司 2023-02-14 — — CN disclosed
CN-115348819-A Non-corrosive formulated compositions for nitrogen inhibitors 沃戴申生命科学美国有限责任公司 2022-11-15 — — CN disclosed
CN-115334884-A Chlorodiidine compositions for increasing nitrogen nutrient use efficiency and improving plant growth 沃戴申生命科学美国有限责任公司 2022-11-11 — — CN disclosed
EP-3885343-A1 INDOLE COMPOUNDS AS EZH2 INHIBITORS AND USES THEREOF Dana-Farber Cancer Institute, Inc. (US) 2021-09-29 — — EP disclosed
CN-107924123-B Material for lithography, method for producing same, composition for lithography, method for forming pattern, compound, resin, and method for purifying same 学校法人关西大学 2021-08-06 — — CN disclosed
US-11046886-B2 Method for producing liquid composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2021-06-29 — — US disclosed
WO-2020226150-A1 COMPOUND AND PRODUCTION METHOD THEREOF, RESIN, COMPOSITION, RESIST FILM, PATTERN FORMING METHOD, UNDERLAYER FILM FOR LITHOGRAPHY, OPTICAL COMPONENT, AND METHOD FOR PURIFYING COMPOUND OR RESIN 学校法人 関西大学 2020-11-12 — — WO disclosed
EP-0922712-B1 Novel electron donor containing compositions UNION CARBIDE CHEM PLASTIC (US) 2002-12-18 — — EP disclosed
US-6399837-B1 POLYMERIZATION CATALYST FOR OLEFINS UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION 2002-06-04 — — US disclosed
US-6124507-A USED IN THE MANUFACTURE OF OLEFIN POLYMERIZATION CATALYSTS WITH PROCATALYSTS HAVING MAGNESIUM, TITANIUM AND HALIDE AS ESSENTIAL COMPONENTS. 1-ETHOXY-2-ALKOXY-4,5,6-OPTIONALLY SUBSTITUTED BENZENES UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 2000-09-26 — — US disclosed
US-5968865-A COORDINATION CATALYST COMPRISING MAGNESIUM, TITANIUM, HALIDE, AND 1,2-DIALKOXYBENZENE COMPOUNDS; OLEFIN POLYMERIZATION CATALYSTS UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1999-10-19 — — US disclosed
EP-0926119-A1 Dialkoxybenzene electron donors UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1999-06-30 — — EP disclosed
EP-0922712-A1 Novel electron donor containing compositions UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1999-06-16 — — EP disclosed
US-4272634-A Process for the production of intermediate oxidation products of toluenes having ether linkages DIRECTOR-GENERAL OF AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 1981-06-09 — — US disclosed
US-4220605-A LIQUID PHASE USING A SOLVENT OF LOW LOWER CARBOXYLIC ACID OR ANHYDRIDE, A SOLUBLE COBALT SALT AND BROMINE OR A BROMINE COMPOUND DIRECTOR GENERAL OF AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 1980-09-02 — — US disclosed
US-4195184-A Preparation of unsaturated monoesters by catalytic oxidative carbonylation of diolefins ATLANTIC RICHFIELD COMPANY (US) 1980-03-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11852970-B2 Material for lithography, production method therefor, composition for lithography, pattern formation method, compound, resin, and method for purifying the compound or the resin SLC39A11, CROCC, TERB1 ALDH1A1 3830/4885PTPN1 4528/4885KDM4E 3079/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback